What is the appropriate levofloxacin dose for an adult patient with normal renal and hepatic function?

Levofloxacin Dosing in Adults with Normal Renal Function

For adults with normal renal function (creatinine clearance ≥50 mL/min), levofloxacin is dosed at 250 mg, 500 mg, or 750 mg orally once every 24 hours, with the specific dose determined by the type and severity of infection being treated. 1

Standard Dosing by Indication

The FDA-approved dosing regimen varies based on infection type:

• Community-acquired pneumonia (CAP):

  • 750 mg once daily for 5 days (high-dose, short-course regimen) 1, 2
  • Alternative: 500 mg once daily for 7-10 days 3

• Acute bacterial sinusitis:

  • 750 mg once daily for 5 days 1, 2

• Complicated urinary tract infections and acute pyelonephritis:

  • 750 mg once daily for 5 days 1, 2

• Bone and joint infections:

  • 500 mg once daily (typical duration 13 weeks median) 4, 5

Key Pharmacokinetic Considerations

Levofloxacin exhibits excellent oral bioavailability (approaching 100%) with peak concentrations reached within 1-2 hours 6. The elimination half-life ranges from 6-8 hours, supporting once-daily dosing 1, 7. Approximately 80% is excreted unchanged in urine, making renal function the primary determinant of clearance 6.

The high-dose (750 mg) short-course regimen maximizes concentration-dependent bactericidal activity and has been shown to be noninferior to traditional 10-day regimens for CAP and sinusitis, while potentially reducing resistance emergence 2.

Administration Guidelines

• Can be taken without regard to food 1
• Must be separated from antacids, iron, multivitamins with zinc, or sucralfate by at least 2 hours (before or after) to avoid significant absorption reduction 1, 6
• Maintain adequate hydration to prevent crystalluria 1

Pharmacodynamic Targets

For optimal outcomes:

• Gram-negative infections: Target AUC/MIC ratio ≥100-125 7, 5
• Gram-positive infections (including S. pneumoniae): Target AUC/MIC ratio ≥30 7

Recent population pharmacokinetic modeling suggests that for patients with creatinine clearance 50-89 mL/min and MIC 0.5 mg/L, 500 mg daily achieves targets for Gram-positive bacteria, but 1000 mg daily may be required for Gram-negative infections requiring AUC/MIC ≥100 8.

Important Caveats

• No dose adjustment needed for age or gender alone when renal function is accounted for 1, 6
• The 750 mg high-dose regimen demonstrates similar tolerability to standard dosing 2
• For infections with Pseudomonas aeruginosa, therapeutic drug monitoring is recommended due to higher MIC values 5
• Weight may influence dosing requirements, particularly in extremes (<40 kg or >70 kg), though standard dosing remains appropriate for most patients 8, 9